Medicare Enrolled
Dr. Jorge Ayub, M.D.
Medical Oncology · Hudson, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ayub from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ayub? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ayub
Dr. Jorge Ayub is a medical oncology in Hudson, FL, with 20 years in practice. Based on federal Medicare data, Dr. Ayub performed 80,874 Medicare services across 2,440 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ayub received a total of $22,374 from 82 pharmaceutical and/or device companies across 753 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ayub is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 28% volume in FL$ $22,374 industry payments
Medicare Practice Summary
Medicare Utilization ↗80,874
Medicare services
Top 28% in FL for medical oncology
2,440
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,044 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 35,190 | $0 | $4 |
| Iron sucrose injection (Venofer) | 23,200 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 7,224 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 5,820 | $18 | $51 |
| Complete blood count (CBC) with differential | 1,413 | $8 | $29 |
| Blood draw (venipuncture) | 1,241 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,065 | $0 | $3 |
| Drug injection, under skin or into muscle | 821 | $10 | $69 |
| Anti-nausea injection (Aloxi/palonosetron) | 610 | $1 | $28 |
| Office visit, established patient (30-39 min) | 542 | $94 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 512 | $0 | $9 |
| Office visit, established patient (20-29 min) | 454 | $65 | $239 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 389 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 298 | $46 | $189 |
| Injection of additional new drug or substance into vein | 293 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 240 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 210 | $16 | $56 |
| Injection, zoledronic acid, 1 mg | 183 | $7 | $69 |
| Prothrombin time test (blood clotting) | 115 | $4 | $15 |
| Injection, diphenhydramine hcl, up to 50 mg | 110 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 106 | $21 | $84 |
| Administration of chemotherapy into vein, each additional hour | 81 | $21 | $79 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 78 | $25 | $89 |
| Office visit, established patient, complex (40-54 min) | 59 | $138 | $474 |
| Administration of additional new drug or substance into vein, 1 hour or less | 53 | $49 | $178 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $16 | $59 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 50 | $3 | $11 |
| Injection of drug or substance into vein | 49 | $25 | $156 |
| Hospital follow-up visit, moderate complexity | 48 | $63 | $197 |
| Automated urinalysis | 45 | $2 | $8 |
| Hospital follow-up visit, high complexity | 42 | $94 | $285 |
| Drawing of blood for a medical problem | 36 | $63 | $277 |
| Initial hospital admission, high complexity | 36 | $127 | $556 |
| Initial hospital admission, moderate complexity | 35 | $103 | $377 |
| Office visit, established patient (10-19 min) | 33 | $41 | $147 |
| Infusion, normal saline solution , 1000 cc | 29 | $2 | $7 |
| New patient office visit (45-59 min) | 28 | $119 | $453 |
| Infusion into a vein for hydration, each additional hour | 24 | $10 | $42 |
| Red blood count, automated test | 23 | $4 | $10 |
| Infusion into a vein for hydration, 31-60 minutes | 21 | $24 | $156 |
| New patient office visit (30-44 min) | 15 | $77 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.4% high complexity
50.4% medium
5.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,374
Total received (2018-2024)
Avg $3,196/year across 7 years
Top 23% in FL for medical oncology
82
Companies
753
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,582 (56.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,787 (43.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,975
2023$2,380
2022$3,774
2021$2,785
2020$6,369
2019$3,320
2018$1,771
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$4,861
Janssen Biotech, Inc.
$2,967
Seagen Inc.
$1,789
Celgene Corporation
$1,428
Eisai Inc.
$1,293
Novartis Pharmaceuticals Corporation
$860
E.R. Squibb & Sons, L.L.C.
$842
PFIZER INC.
$685
Genentech USA, Inc.
$653
Adaptive Biotechnologies Corporation
$600
Daiichi Sankyo Inc.
$543
Amgen Inc.
$307
Bayer HealthCare Pharmaceuticals Inc.
$306
GENZYME CORPORATION
$274
Merck Sharp & Dohme Corporation
$227
GlaxoSmithKline, LLC.
$211
Merck Sharp & Dohme LLC
$211
Lilly USA, LLC
$209
Medtronic Vascular, Inc.
$206
Gilead Sciences, Inc.
$206
Incyte Corporation
$189
Pharmacyclics LLC, An AbbVie Company
$172
Astellas Pharma US Inc
$171
Mirati Therapeutics, Inc.
$155
EMD Serono, Inc.
$145
Regeneron Healthcare Solutions, Inc.
$138
BeiGene USA, Inc.
$127
Ipsen Biopharmaceuticals, Inc
$126
Bayer Healthcare Pharmaceuticals Inc.
$113
ABBVIE INC.
$109
PUMA BIOTECHNOLOGY, INC.
$102
Blueprint Medicines Corporation
$99
Takeda Pharmaceuticals U.S.A., Inc.
$93
Jazz Pharmaceuticals Inc.
$78
JAZZ PHARMACEUTICALS INC.
$77
Alexion Pharmaceuticals, Inc.
$74
ARRAY BIOPHARMA INC
$73
Seattle Genetics, Inc.
$72
Karyopharm Therapeutics Inc.
$70
SERVIER PHARMACEUTICALS LLC
$68
Tempus AI, Inc
$63
TESARO, Inc.
$62
EISAI INC.
$62
TAIHO ONCOLOGY, INC.
$60
Foundation Medicine, Inc.
$60
AVEO Pharmaceuticals, Inc.
$59
Pharmacyclics LLC, an AbbVie Company
$54
MorphoSys, US Inc.
$52
Kite Pharma, Inc.
$51
Sumitomo Pharma America, Inc.
$50
AbbVie Inc.
$50
Apellis Pharmaceuticals, Inc.
$49
Janssen Pharmaceuticals, Inc
$47
EUSA Pharma (US) LLC
$42
MEDIVATION FIELD SOLUTIONS LLC
$41
Puma Biotechnology, Inc.
$39
Genmab U.S., Inc.
$39
Myovant Sciences Inc.
$35
Agios Pharmaceuticals, Inc.
$35
AbbVie, Inc.
$34
Deciphera Pharmaceuticals Inc.
$32
ADC Therapeutics America, Inc.
$32
Epizyme, Inc.,
$30
GE HealthCare
$30
Array BioPharma Inc.
$30
Exelixis Inc.
$29
Myriad Genetic Laboratories, Inc.
$28
Fennec Pharmaceuticals, Inc.
$25
Servier Pharmaceuticals LLC
$25
Rigel Pharmaceuticals, Inc.
$25
SECURA BIO, INC.
$25
PORTOLA PHARMACEUTICALS, INC.
$20
Dova Pharmaceuticals
$16
CTI BioPharma Corp.
$16
PharmaEssentia USA Corporation
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
G1 Therapeutics, Inc.
$15
SOBI, INC
$15
Aveo Pharmaceuticals, Inc.
$15
TerSera Therapeutics LLC
$12
Aurobindo Pharma USA, Inc.
$11
Veracyte, Inc.
$1
Top 3 companies account for 43.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Columvi · DARZALEX · Doptelet · ELITEK · ELREXFIO · EMEND · ENHERTU · EPKINLY · ERLEADA · Empaveli · Endurant · Enhertu · Epkinly · Erivedge · Erleada · FOTIVDA · FOUNDATIONONE · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Pedmark · Perjeta · Phesgo · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XERMELO · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $28 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
12
Per 100K population
2.0
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ayub is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ayub experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ayub performed 35,190 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ayub receive payments from pharmaceutical companies?
Yes. Dr. Ayub received a total of $22,374 from 82 companies across 753 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ayub's costs compare to other medical oncologys in Hudson?
Dr. Ayub's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ayub) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Hudson
Browse medical oncologys in Hudson ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology